Skip to main content
All lobbying filings

CENCORA, INC.

Lobbying for CENCORA, INC.

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $680,000.00 expenses · posted Oct 20, 2025

Official filing document

 Bills named in this filing 7
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 3164
    Ensuring Community Access to Pharmacist Services Act
  • S 2426
    Equitable Community Access to Pharmacist Services Act
  • HR 4132
    Prescription Information Modernization Act of 2025
  • S 2027
    Prescription Information Modernization Act of 2025
  • HR 2483
    SUPPORT for Patients and Communities Reauthorization Act of 2025
  • S 2121
    SUPPORT for Patients and Communities Reauthorization Act of 2025
 Lobbying activity 4
Taxation/Internal Revenue Code

One Big Beautiful Bill Act/Budget Reconciliation (H.R.1) Tariff proposed policies LIFO accounting method Global Intangible Low-taxed Income (GILTI)

Medicare/Medicaid

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). CMS Proposed Medicare Physician Fee Schedule Rule Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages

Pharmacy

Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)

Health Issues

Strategic National Stockpile. Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483/S.2121) Medical Supply Resiliency Act National Defense Authorization Act FY2026 (NDAA) Supply Chain Resiliency Most Favored Nation drug pricing proposals One Big Beautiful Bill Act / Budget Reconciliation (H.R.1) CMS Proposed Medicare Physician Fee Schedule Rule

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem